Prostate Cancer

Top-Ranked Program Nationwide for Prostate Cancer

Loyola Medicine is recognized as having a prostate cancer program that is among the finest in the nation. 

According to the American Cancer Society, one in seven men will be diagnosed with prostate cancer in his lifetime. Prostate cancer is the most common cause of death from cancer in men over age 75, and is rarely found in men younger than 40.

Our interdisciplinary team of doctors provides an integrated approach to the diagnosis and treatment of prostate cancer. In fact, our urology department is the only program in the Chicago area recognized as being among the nation’s “Clinical Centers of Excellence” for prostate cancer by Urology Times, a leading source of news and analysis about key advances in the field of urology.

Why Choose Loyola for the Treatment of Prostate Cancer?

Loyola Medicine is the first hospital system in Illinois to use a new combination MRI-ultrasound imaging system that can result in fewer biopsies and better treatment decisions for prostate cancer patients. The technology, called UroNav®, fuses images from MRI (magnetic resonance imaging) with ultrasound to create a detailed, three-dimensional view of the prostate. This improved view helps physicians perform biopsies with much higher precision and increases prostate cancer detection.

The members of our team are fellowship trained in urologic oncology and are thought leaders in the use of robotic surgery for prostate cancer treatment. 

In addition, cancer specialists at Loyola are constantly seeking new ways to provide better, more effective care for their patients. Loyola is a leader in using prostate seed brachytherapy to treat prostate cancer. 

What is Prostate Cancer?

The prostate gland is a walnut-sized structure that makes up part of a man’s reproductive system. It wraps around the urethra, which is the tube that carries urine out of the body. The prostate gland can grow in size as a man ages, which can lead to a common condition called BPH (benign prostatic hyperplasia). BPH is not cancer and does not develop into cancer. 
 
Prostate cancer is a malignant tumor that begins in the prostate gland. Almost all prostate cancers develop in the gland cells, which make the prostate fluid that is added to semen. The medical term for a cancer that starts in gland cells is adenocarcinoma.

How is Prostate Cancer Diagnosed?

Doctors at Loyola approach the diagnosis of prostate cancer with great care. In most cases, men will seek medical advice and testing if they experience any of the most common prostate cancer symptoms, which include:

  • Blood in the urine or semen
  • Incontinence
  • Persistent pain
  • Weak urinary stream

Prostate cancer can also be detected during screenings such as a PSA test or a digital rectal exam.
 
A man’s symptoms, personal and family medical history, physical exam and screening tests can help diagnose his cancer. However, the actual diagnosis can only be made with a prostate biopsy. 
 
Biopsy results are reported using a tumor grade (Gleason grade). The higher your tumor grade, the more likely the cancer is to have spread past the prostate. Depending on your tumor grade, the team at Loyola may recommend the following tests to determine if the cancer has spread:

How is Prostate Cancer Treated?

Loyola’s interdisciplinary approach to the treatment of prostate cancer brings together a wide range of board-certified medical experts who evaluate your condition and provide a comprehensive, individualized plan for treatment.
 
Prostate cancer treatment depends on many things, including your tumor grade and your overall health. Your treatment may include:

Loyola’s radiation oncologists perform a large number of prostate brachytherapy procedures annually.  This means we have extensive experience using this cancer treatment to remove tumors, reduce cancer symptoms and give you the best possible outcomes. Learn more about prostate seed brachytherapy.

Screening Recommendations for Prostate Cancer

Loyola follows the American Urological Association’s screening guidelines for early detection and prevention of prostate cancer. The American Cancer Society also recommends that men make an informed decision with their doctor about whether to be tested for prostate cancer. 

Learn more about prostate cancer screening guidelines.